Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDQuarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2025 | 1 | -$0.05 | -$0.04 | -$0.05 |
Q2 2025 | 1 | -$0.03 | -$0.03 | -$0.03 |
Q3 2025 | 1 | -$0.00 | -$0.00 | -$0.00 |
Q4 2025 | 1 | $0.03 | $0.03 | $0.03 |
Q1 2026 | 1 | $0.07 | $0.07 | $0.07 |
Q2 2026 | 1 | $0.07 | $0.07 | $0.07 |
Q3 2026 | 1 | $0.07 | $0.07 | $0.07 |
Q4 2026 | 1 | $0.10 | $0.10 | $0.10 |
LifeMD, Inc. last posted its earnings results on Monday, March 10th, 2025. The company reported $-0.02 earnings per share for the quarter, topping analysts' consensus estimates of $-0.04 by $0.02. The company had revenue of 64.25 M for the quarter and had revenue of 212.45 M for the year. LifeMD, Inc. has generated $-1 earnings per share over the last year ($-0.53 diluted earnings per share) and currently has a price-to-earnings ratio of -11.16. LifeMD, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 6th, 2025 based on prior year's report dates.
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
03/11/2025 | Q4 2024 | N/A | -$0.00 | N/A | $57.47 M | $64.25 M |
11/07/2024 | Q3 2024 | -$0.10 | -$0.14 | -0.04 | $53.82 M | $40.28 M |
08/07/2024 | Q2 2024 | -$0.13 | -$0.17 | -0.04 | $48.46 M | $50.66 M |
05/08/2024 | Q1 2024 | -$0.13 | -$0.17 | -0.04 | $42.59 M | $44.14 M |
03/11/2024 | Q4 2023 | -$0.14 | -$0.10 | 0.04 | $41.30 M | $44.86 M |
11/08/2023 | Q3 2023 | -$0.18 | -$0.18 | 0 | $38.44 M | $38.61 M |
08/09/2023 | Q2 2023 | -$0.09 | -$0.21 | -0.12 | $35.15 M | $35.95 M |
05/12/2023 | Q1 2023 | -$0.16 | -$0.32 | -0.16 | $30.81 M | $33.13 M |
03/22/2023 | Q4 2022 | $0.18 | -$0.37 | -0.55 | $33.58 M | $28.12 M |
11/10/2022 | Q3 2022 | -$0.27 | -$0.27 | 0 | $31.85 M | $31.41 M |
08/11/2022 | Q2 2022 | -$0.23 | -$0.43 | -0.2 | $31.31 M | $30.46 M |
05/13/2022 | Q1 2022 | -$0.26 | -$0.44 | -0.18 | $31.53 M | $29.04 M |
03/07/2022 | Q4 2021 | -$0.39 | -$0.68 | -0.29 | $27.46 M | $27.42 M |
11/10/2021 | Q3 2021 | -$0.49 | -$0.54 | -0.05 | $25.28 M | $24.95 M |
08/13/2021 | Q2 2021 | N/A | -$0.64 | N/A | $21.78 M | $22.31 M |
05/14/2021 | Q1 2021 | N/A | -$0.47 | N/A | $18.22 M | $18.20 M |
03/30/2021 | Q4 2020 | N/A | -$2.57 | N/A | $13.26 M | $12.89 M |
11/16/2020 | Q3 2020 | N/A | -$1.33 | N/A | N/A | $11.01 M |
08/14/2020 | Q2 2020 | N/A | -$0.24 | N/A | N/A | $9.09 M |
05/19/2020 | Q1 2020 | N/A | -$0.23 | N/A | N/A | $4.30 M |
LifeMD, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 6th, 2025 based offlast year's report dates.
In the previous quarter, LifeMD, Inc. (:LFMD) reported $-0.02 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.04 by $0.02.
The conference call for LifeMD, Inc.'s latest earnings report can be listened to online.
The conference call transcript for LifeMD, Inc.'s latest earnings report can be read online.
LifeMD, Inc. (:LFMD) has a recorded annual revenue of $212.45 M.
LifeMD, Inc. (:LFMD) has a recorded net income of $-18,881,732.LifeMD, Inc. has generated $-0.53 earnings per share over the last four quarters.
LifeMD, Inc. (:LFMD) has a price-to-earnings ratio of -11.16 and price/earnings-to-growth ratio is -0.65.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED